- The Washington Times - Tuesday, March 15, 2005

NEW YORK (AP) — Nagging concerns about inflation bogged down Wall Street yesterday, with investors sending stocks lower as they tried to reconcile solid economic and earnings news, reports of anthrax possibly being found at the Pentagon, and a gloomy outlook on semiconductor stocks.

Concerns that higher oil prices, which topped $55 per barrel, would accelerate inflation and lead to rising interest rates eroded investor confidence, and the Pentagon’s concern about possible anthrax contamination in its mailroom added to the general unease. The technology sector was hit particularly hard after a Merrill Lynch analyst said growth in chip stocks would be stalled for much of the year.

That made it difficult for Wall Street to rise on good news from the retail sector. While the 0.5 percent growth in February retail sales fell slightly below Wall Street expectations, the Commerce Department revised its January figure upward, and auto sales were surprisingly strong in both months. Record earnings from Lehman Brothers Holdings Inc. were likewise discounted by midday, when stocks turned firmly negative.

The Dow Jones Industrial Average fell 59.41, or 0.55 percent, to 10,745.10.

Broader stock indicators also lost ground. The Standard & Poor’s 500 Index was down 9.08, or 0.75 percent, at 1,197.75, and the tech-focused Nasdaq Composite Index, hurt by the Merrill Lynch report, lost 16.06, or 0.78 percent, to 2,034.98.

All three major indexes finished at or near their lows for the session.

Oil prices rose as investors worried that OPEC may not follow Saudi Arabia’s lead and increase oil production. A barrel of light crude settled at $55.05, up 10 cents, on the New York Mercantile Exchange.

Wall Street paid close attention to Federal Reserve Chairman Alan Greenspan’s testimony on Capitol Hill, hoping to hear his latest views on inflation and interest rates. Mr. Greenspan, whose topic yesterday was Social Security, warned that federal budget deficits, not inflation, remained the greatest threat to the economy.

Lehman Brothers’ earnings benefited from strong investment banking revenue and advisory fees from the recent wave of merger activity. The brokerage beat Wall Street estimates by 71 cents per share. Lehman gained $2.87 to $96.19.

The Philadelphia Semiconductor Index was off 2.12 percent in response to the Merrill Lynch report on chip stocks, while Dow component Intel Corp. fell 39 cents to $23.88 and Advanced Micro Devices Inc. lost 37 cents to $16.07.

“The Nasdaq didn’t even see much of the upside we had earlier in the day because of the semis,” said Bill Groenveld, head trader for VFinance Investments. “There’s just so much stuff out there that nobody can make heads or tails of, you’re just going to go lower out of inertia.”

Drug maker Genentech Inc. slid 75 cents to $54.25 after having been strongly higher most of the session. The company announced that studies showed its colon cancer drug Avastin was effective in treating lung cancer patients as well. The news led to two brokerage upgrades of Genentech’s stock.

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times welcomes your comments on Spot.im, our third-party provider. Please read our Comment Policy before commenting.


Click to Read More and View Comments

Click to Hide